Trials / Completed
CompletedNCT00406341
Study of Difluprednate Ophthalmic Emulsion in Postoperative Inflammation
Phase 3 Confimatory Study of 0.05% Difluprednate Ophthalmic Emulsion in the Treament of Postoperative Inflammation
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 200 (planned)
- Sponsor
- Sirion Therapeutics, Inc. · Industry
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this phase 3 study is to determine if difluprednate ophthalmic emulsion is effective in the treatment of postoperative inflammation.
Detailed description
The objective of this phase 3 study is to assess the efficacy and safety of 0.05% difluprednate ophthalmic emulsion in patients with intraocular postoperative inflammation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Difluprednate Ophthalmic Emulsion |
Timeline
- Start date
- 2004-04-01
- Completion
- 2005-03-01
- First posted
- 2006-12-04
- Last updated
- 2006-12-04
Source: ClinicalTrials.gov record NCT00406341. Inclusion in this directory is not an endorsement.